Duke curtails laboratory research as a Result of the COVID-19 outbreak

PIs of Duke research laboratories were asked to develop contingency plans in the event of a campus shutdown as a result of the COVID-19 outbreak. This message is to inform you that we must now implement these plans, which will severely curtail laboratory research activities on Duke’s campus and in our leased facilities.For more information visit Duke Research.

Duke CTSI announces the 2019-20 Translational Accelerator awardees

Duke CTSI has announced the winners of its 2018 Translational Accelerator Award RFA. Three projects have been selected for their outstanding potential to translate scientific discoveries into better outcomes in a clinical and population settings.

The awardees for the Translational Accelerator Awards (2019-2020 cycle) are:

Optical Assessment of Retinal Microvascular Ischemia in Cardiopulmonary Bypass
Principal Investigator: Cynthia Toth
Co-Investigators: Quintin Quinones, Sidney Gospe, Joseph Izatt, Christian Viehland, Sandra Stinnett

Sensitization of Pancreatic Cancer to Chemotherapy
Principal Investigator: Pei Zhou
Co-Investigators: Fan Yuan, Jiyong Hong

AAV Mediated Gene Therapy of A Mouse Model of Alternating Hemiplegia of Childhood
Principal Investigator: Mohamad Mikati
Co-Investigators: Boris Kantor, Dwight Koeberl

Funding support for Core Research Facility

The Duke Preclinical Translational Research Unit has received 3 years funding from the School of Medicine as a new Core Research Facility with approval from Raphael Valdivia, PhD, Vice Dean for Basic Science. We are grateful to Dr. Valdivia and the support from the SOM.

DCI Pilot Resource Funding

The Duke Preclinical Translational Research Unit has received funding support from the Duke Cancer Institute as a pilot shared resource. We are grateful to Michael Kastan, MD, PhD, Executive Director of the Duke Cancer Institute, and Mark Dewhirst, DVM, PhD, Director of the DCI Shared Resources Oversight Committee for their support.